Your browser doesn't support javascript.
loading
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.
Madden, Jeanne M; Graves, Amy J; Zhang, Fang; Adams, Alyce S; Briesacher, Becky A; Ross-Degnan, Dennis; Gurwitz, Jerry H; Pierre-Jacques, Marsha; Safran, Dana Gelb; Adler, Gerald S; Soumerai, Stephen B.
Afiliação
  • Madden JM; Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Ave, 6th Floor, Boston, Massachusetts 02215, USA. jeanne_madden@hms.harvard.edu
JAMA ; 299(16): 1922-8, 2008 Apr 23.
Article em En | MEDLINE | ID: mdl-18430911
ABSTRACT
CONTEXT Cost-related medication nonadherence (CRN) has been a persistent problem for individuals who are elderly and disabled in the United States. The impact of Medicare prescription drug coverage (Part D) on CRN is unknown.

OBJECTIVE:

To estimate changes in CRN and forgoing basic needs to pay for drugs following Part D implementation. DESIGN, SETTING, AND

PARTICIPANTS:

In a population-level study design, changes in study outcomes between 2005 and 2006 before and after Medicare Part D implementation were compared with historical changes between 2004 and 2005. The community-dwelling sample of the nationally representative Medicare Current Beneficiary Survey (unweighted unique n = 24,234; response rate, 72.3%) was used, and logistic regression analyses were controlled for demographic characteristics, health status, and historical trends. MAIN OUTCOME

MEASURES:

Self-reports of CRN (skipping or reducing doses, not obtaining prescriptions) and spending less on basic needs to afford medicines.

RESULTS:

The unadjusted, weighted prevalence of CRN was 15.2% in 2004, 14.1% in 2005, and 11.5% after Part D implementation in 2006. The prevalence of spending less on basic needs was 10.6% in 2004, 11.1% in 2005, and 7.6% in 2006. Adjusted analyses comparing 2006 with 2005 and controlling for historical changes (2005 vs 2004) demonstrated significant decreases in the odds of CRN (ratio of odds ratios [ORs], 0.85; 95% confidence interval [CI], 0.74-0.98; P = .03) and spending less on basic needs (ratio of ORs, 0.59; 95% CI, 0.48-0.72; P < .001). No significant changes in CRN were observed among beneficiaries with fair to poor health (ratio of ORs, 1.00; 95% CI, 0.82-1.21; P = .97), despite high baseline CRN prevalence for this group (22.2% in 2005) and significant decreases among beneficiaries with good to excellent health (ratio of ORs, 0.77; 95% CI, 0.63-0.95; P = .02). However, significant reductions in spending less on basic needs were observed in both groups (fair to poor health ratio of ORs, 0.60; 95% CI, 0.47-0.75; P < .001; and good to excellent health ratio of ORs, 0.57; 95% CI, 0.44-0.75; P < .001).

CONCLUSIONS:

In this survey population, there was evidence for a small but significant overall decrease in CRN and forgoing basic needs following Part D implementation. However, no net decrease in CRN after Part D was observed among the sickest beneficiaries, who continued to experience higher rates of CRN.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Recusa do Paciente ao Tratamento / Custos de Medicamentos / Uso de Medicamentos / Medicare Part D Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Recusa do Paciente ao Tratamento / Custos de Medicamentos / Uso de Medicamentos / Medicare Part D Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Estados Unidos